Concepedia

Publication | Open Access

Neoadjuvant programmed death-1 blockade plus chemotherapy in locally advanced esophageal squamous cell carcinoma

54

Citations

24

References

2021

Year

Abstract

Neoadjuvant camrelizumab plus nab-paclitaxel and S1 is safe, feasible and effective in locally advanced ESCC and is worth further investigation.

References

YearCitations

Page 1